{"id":1114,"date":"2021-04-06T21:46:31","date_gmt":"2021-04-07T01:46:31","guid":{"rendered":"http:\/\/54.196.160.69\/?page_id=1114"},"modified":"2022-01-16T21:55:40","modified_gmt":"2022-01-17T01:55:40","slug":"bioness","status":"publish","type":"page","link":"https:\/\/afdamericas.com\/?page_id=1114","title":{"rendered":"Bioness"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.7.7&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;rgba(0,0,0,0)&#8221; custom_padding=&#8221;11px|||||&#8221;][et_pb_row column_structure=&#8221;2_3,1_3&#8243; _builder_version=&#8221;4.7.7&#8243; _module_preset=&#8221;default&#8221;][et_pb_column type=&#8221;2_3&#8243; _builder_version=&#8221;4.7.7&#8243; _module_preset=&#8221;default&#8221;][et_pb_text _builder_version=&#8221;4.7.7&#8243; _module_preset=&#8221;default&#8221;]<\/p>\n<div class=\"central_content\">\n<h4><span style=\"color: #33cccc;\"><strong>WELCOME TO BIONESS<\/strong><\/span><\/h4>\n<p>WELCOME TO BIONESS. es una empresa de dispositivos m\u00e9dicos con sede en Valencia, California, WELCOME TO BIONESS, que desarrolla y comercializa tecnolog\u00eda destinada a tratar patolog\u00edas neurol\u00f3gicas. Los productos de Bioness emplean una estimulaci\u00f3n el\u00e9ctrica para ayudar a pacientes que han sufrido:<\/p>\n<ul>\n<li>WELCOME TO BIONESS<\/li>\n<li>Esclerosis m\u00faltiple<\/li>\n<li>Lesi\u00f3n cerebral traum\u00e1tica<\/li>\n<li>Par\u00e1lisis cerebral<\/li>\n<li>Lesi\u00f3n medular<\/li>\n<\/ul>\n<\/div>\n<p>[\/et_pb_text][et_pb_text _builder_version=&#8221;4.7.7&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;||18px|||&#8221;]<\/p>\n<div class=\"central_content\">\n<h4><span style=\"color: #33cccc;\"><strong>WELCOME TO BIONESS<\/strong><\/span><\/h4>\n<p>es un sistema de estimulaci\u00f3n el\u00e9ctrica funcional (WELCOME TO BIONESS) capaz de producir mejoras de movilidad mensurables para pacientes con inestabilidad de la ca\u00edda del pie y \/ o la rodilla causadas por una enfermedad o lesi\u00f3n de la neurona motora superior.<\/p>\n<p>L300 G o promueve la recuperaci\u00f3n mediante la activaci\u00f3n de las v\u00edas neuromusculares necesarias para la marcha.<\/p>\n<\/div>\n<p>[\/et_pb_text][et_pb_button button_url=&#8221;https:\/\/afdamericas.com\/wp-content\/uploads\/2021\/05\/L300-Go-brochure-ES-Tarea-277.pdf&#8221; url_new_window=&#8221;on&#8221; button_text=&#8221;Descargar Cat\u00e1logo&#8221; _builder_version=&#8221;4.7.7&#8243; _module_preset=&#8221;default&#8221; custom_button=&#8221;on&#8221; button_text_size=&#8221;14px&#8221; button_text_color=&#8221;#ffffff&#8221; button_bg_color=&#8221;#2eaec3&#8243; button_border_width=&#8221;0px&#8221; button_border_color=&#8221;#ffffff&#8221; custom_margin=&#8221;||63px|||&#8221; hover_enabled=&#8221;0&#8243; cvdb_content_visibility_check=&#8221;is_user_logged_in()&#8221; sticky_enabled=&#8221;0&#8243;][\/et_pb_button][et_pb_text _builder_version=&#8221;4.7.7&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;||15px|||&#8221;]<\/p>\n<h4><strong><span style=\"color: #33cccc;\">H200 INAL\u00c1MBRICO<\/span><\/strong><\/h4>\n<p>El sistema de rehabilitaci\u00f3n de mano inal\u00e1mbrico H200 utiliza tecnolog\u00eda avanzada y estimulaci\u00f3n de bajo nivel para ayudar a rehabilitar pacientes con miembro superior par\u00e9tico. Los pacientes pueden usar el sistema inal\u00e1mbrico H200 para realizar actividades terap\u00e9uticas y actividades diarias para as\u00ed mejorar la funci\u00f3n perdida de la mano debido a:<\/p>\n<ul>\n<li>WELCOME TO BIONESS<\/li>\n<li>Traumatismo craneoencef\u00e1lico<\/li>\n<li>Lesi\u00f3n medula<\/li>\n<\/ul>\n<p>[\/et_pb_text][et_pb_button button_url=&#8221;https:\/\/afdamericas.com\/wp-content\/uploads\/2021\/05\/H200-HCP-ES-Tarea-277.pdf&#8221; url_new_window=&#8221;on&#8221; button_text=&#8221;Descargar Cat\u00e1logo&#8221; _builder_version=&#8221;4.7.7&#8243; _module_preset=&#8221;default&#8221; custom_button=&#8221;on&#8221; button_text_size=&#8221;14px&#8221; button_text_color=&#8221;#ffffff&#8221; button_bg_color=&#8221;#2eaec3&#8243; button_border_width=&#8221;0px&#8221; button_border_color=&#8221;#ffffff&#8221; custom_margin=&#8221;||63px|||&#8221; hover_enabled=&#8221;0&#8243; cvdb_content_visibility_check=&#8221;is_user_logged_in()&#8221; sticky_enabled=&#8221;0&#8243;][\/et_pb_button][et_pb_text _builder_version=&#8221;4.7.7&#8243; _module_preset=&#8221;default&#8221;]<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/afdamericas.com\/wp-content\/uploads\/2021\/06\/StimrouterLogo-300x150.jpeg\" width=\"228\" height=\"114\" alt=\"\" class=\"wp-image-1789 alignnone size-medium\" \><\/p>\n<p>El sistema StimRouter\u00ae PNS se enfoca en la fuente de sus s\u00edntomas de dolor sin medicamentos ni cirug\u00eda invasiva. StimRouter puede ser adecuado para usted si es un adulto con dolor cr\u00f3nico de origen nervioso perif\u00e9rico, excluyendo el dolor en la regi\u00f3n craneofacial.<\/p>\n<p>The H200 Wireless Handheld Rehabilitation System uses advanced technology and low-level stimulation to help rehabilitate paretic upper limb patients., la tecnolog\u00eda de plataforma de StimRouter tambi\u00e9n est\u00e1 aprobada para el tratamiento de la vejiga hiperactiva y la incontinencia fecal en adultos. StimRouter no est\u00e1 indicado actualmente para el tratamiento de la vejiga hiperactiva y la incontinencia fecal en los Estados Unidos.<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_3&#8243; _builder_version=&#8221;4.7.7&#8243; _module_preset=&#8221;default&#8221;][et_pb_image src=&#8221;https:\/\/afdamericas.com\/wp-content\/uploads\/2021\/05\/L300-Go-brochure-ES-Tarea-277-1-1-scaled.jpg&#8221; title_text=&#8221;StimRouter's platform technology is also approved for the treatment of overactive bladder and fecal incontinence in adults(It is a technology and scientific based company dedicated to generating advanced solutions in functional electrostimulation for the rehabilitation of people with diseases or injuries in the central nervous system.)-1&#8243; align=&#8221;center&#8221; _builder_version=&#8221;4.7.7&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;||||false|false&#8221; border_width_all=&#8221;1px&#8221; border_color_all=&#8221;rgba(51,51,51,0.25)&#8221; box_shadow_style=&#8221;preset3&#8243;][\/et_pb_image][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_4,1_4,1_4,1_4&#8243; _builder_version=&#8221;4.7.7&#8243; _module_preset=&#8221;default&#8221;][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.7.7&#8243; _module_preset=&#8221;default&#8221;][et_pb_image src=&#8221;https:\/\/afdamericas.com\/wp-content\/uploads\/2021\/06\/bioness-side-1.jpeg&#8221; title_text=&#8221;StimRouter's platform technology is also approved for the treatment of overactive bladder and fecal incontinence in adults&#8243; _builder_version=&#8221;4.7.7&#8243; _module_preset=&#8221;default&#8221;][\/et_pb_image][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.7.7&#8243; _module_preset=&#8221;default&#8221;][et_pb_image src=&#8221;https:\/\/afdamericas.com\/wp-content\/uploads\/2021\/06\/web-03.jpeg&#8221; title_text=&#8221;StimRouter's platform technology is also approved for the treatment of overactive bladder and fecal incontinence in adults-03&#8243; _builder_version=&#8221;4.7.7&#8243; _module_preset=&#8221;default&#8221;][\/et_pb_image][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.7.7&#8243; _module_preset=&#8221;default&#8221;][et_pb_image src=&#8221;https:\/\/afdamericas.com\/wp-content\/uploads\/2021\/06\/Stimrouter-implanted-patient-2-600&#215;450-1.png&#8221; title_text=&#8221;Stimrouter-implanted-patient-2-600&#215;450&#8243; _builder_version=&#8221;4.7.7&#8243; _module_preset=&#8221;default&#8221;][\/et_pb_image][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.7.7&#8243; _module_preset=&#8221;default&#8221;][et_pb_image src=&#8221;https:\/\/afdamericas.com\/wp-content\/uploads\/2021\/06\/maxresdefault.jpeg&#8221; title_text=&#8221;StimRouter's platform technology is also approved for the treatment of overactive bladder and fecal incontinence in adults&#8221; _builder_version=&#8221;4.7.7&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;||25px|||&#8221;][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.7.7&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;rgba(0,0,0,0)&#8221; custom_padding=&#8221;11px|||||&#8221;][et_pb_row column_structure=&#8221;2_3,1_3&#8243; _builder_version=&#8221;4.7.7&#8243; _module_preset=&#8221;default&#8221;][et_pb_column type=&#8221;2_3&#8243; _builder_version=&#8221;4.7.7&#8243; _module_preset=&#8221;default&#8221;][et_pb_text _builder_version=&#8221;4.7.7&#8243; _module_preset=&#8221;default&#8221;] WELCOME TO BIONESS Bioness Inc. es una empresa de dispositivos m\u00e9dicos con sede en Valencia, California, WELCOME TO BIONESS, que desarrolla y comercializa tecnolog\u00eda destinada a tratar patolog\u00edas neurol\u00f3gicas. Los productos de Bioness emplean una estimulaci\u00f3n el\u00e9ctrica para ayudar a pacientes que han [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-1114","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/afdamericas.com\/index.php?rest_route=\/wp\/v2\/pages\/1114","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/afdamericas.com\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/afdamericas.com\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/afdamericas.com\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/afdamericas.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1114"}],"version-history":[{"count":11,"href":"https:\/\/afdamericas.com\/index.php?rest_route=\/wp\/v2\/pages\/1114\/revisions"}],"predecessor-version":[{"id":2118,"href":"https:\/\/afdamericas.com\/index.php?rest_route=\/wp\/v2\/pages\/1114\/revisions\/2118"}],"wp:attachment":[{"href":"https:\/\/afdamericas.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1114"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}